Artal Group S.A. — 13F Holdings & Portfolio

CIK 1053906 · latest 13F-HR filed 2026-08-13

Artal Group S.A. manages $931.1M in 13F-reported U.S. long-equity assets across 2 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are CAVA (54.85%), LXRX (45.15%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 0 new positions, exited 0, added to 1, and trimmed 1.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Filer Information
Address
VALLEY PARK
44, RUE DE LA VALLEE
LUXEMBOURG, N4 L-2661
Phone
(352) 224-2591
Filing Manager
Artal Group S.A.
LUXEMBOURG, N4
Signatory
Anne Goffard
Authorized Person
Loading holdings…
AUM

$931.1M

Long-equity book

Holdings

2

Distinct positions

Period

2026-06-30

Filed 2026-08-13

Q/Q Activity

+0 / −0 / ↑1 / ↓1

vs 2026-03-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • Lexicon Pharmaceuticals Inc$179.0M +74.2%
Show all 1 →

Top Trims

  • Cava Group Inc-$258.4M -33.6%
Show all 1 →

New Positions

  • No new positions this quarter.
Show all 0 →

Exited Positions

  • No exits this quarter.
Show all 0 →
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 Cava Group Inc CAVA 148929102 $510.7M 54.85% 6,507,990 SH
2 Lexicon Pharmaceuticals Inc LXRX 528872302 $420.4M 45.15% 175,156,062 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-13 $931.1M 2 0001053906-26-000008
2026-03-31 2026-05-14 $1.01B 2 0001053906-26-000006
2025-12-31 2026-02-12 $714.6M 2 0001053906-26-000003
2025-09-30 2025-11-12 $758.2M 2 0001053906-25-000012